Doxycycline Intervention for Bacterial STI ChemoprOphylaxis (DISCO)
Recruiting now · Not applicable
Conditions studied: Bacterial Sexually Transmitted Diseases
In brief
There is a growing epidemic of the bacterial sexually transmitted infections (STIs) syphilis, chlamydia and gonorrhea worldwide; similarly concerning trends have been noted in Canada, where increases of over 160% have been seen in bacterial STIs over the last decade. In Canada, gay, bisexual, and other men who have sex with men (gbMSM) - including those living with HIV - are disproportionately impacted by bacterial STIs5,6These dramatic increases in bacterial STIs, the potential development of serious complications including AMR, and waning effectiveness of the promotion of conventional STI prevention tools (e.g. condoms), signals the need for novel STI prevention strategies and tools to mitigate STI-related complications. A rigorous randomized controlled trial will be conducted to compare STI PrEP vs. STI PEP and definitively assess the efficacy, safety, antimicrobial resistance profiles and costs associated with doxycycline-based STI prevention.
Key facts
- Study ID
- NCT04762134
- Run by
- Jonathan Troy Grennan
- People needed
- 560
- Starts
- 2023-06-02
- Expected to finish
- 2027-06-30
- Last updated by the study team
- 2024-08-05
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- Males, ≥ 18 years of age;
- Any sexual activity (i.e. oral sex, insertive or receptive anal sex, with or without a condom) with more than one male partner in the preceding 12 months;
- Intention to remain sexually active with more than one male partner in the next 12 months;
- At least one prior episode of a previously diagnosed and adequately treated syphilis, gonorrhea or chlamydia infection within 12 months prior to screening.
You may not qualify if…
- Known allergy to doxycycline or tetracyclines;
- Existing chronic or intermittent tetracycline or doxycycline use (e.g. for chronic osteomyelitis, acne).
- Use of medications which could lower doxycycline levels, including barbiturates, phenytoin and carbamazepine.
- Individuals currently using isotretinoin;
- Any individual capable of becoming pregnant.
Where it is running
- Sheldon Chumir Centre — Calgary, Alberta, Canada (enrolling)
- BC Centre for Disease Control — Vancouver, British Columbia, Canada (enrolling)
- St. Michael's Hospital — Toronto, Ontario, Canada (enrolling)
- McGill University Health Centre — Montreal, Quebec, Canada (enrolling)
- St. Joseph's Healthcare Hamilton — Hamilton, Ontario, Canada
- The Ottawa Hospital — Ottawa, Ontario, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.